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 Approximately 60% of congenital deafness has genetic causes in 
developed countries (Petit et  al, 2001; Picciotti et  al, 2009), with a 
progressive increase of this percentage due to the improvement of 
public health conditions and consequent reduction of hearing impair-
ment linked to other causes such as infections (Marazita et  al, 1993). 
Genetic sensorineural hearing loss (SNHL) is classifi ed as non-syn-
dromic (70%) and syndromic (30%), with an autosomal recessive 
mode of inheritance found in about 70 – 80% of patients. Lower 
percentages are associated with autosomal dominant (15 – 20%), 
X-linked (1%), and mitochondrial (1%) deafness. 
 Mutations in more than 60 genes were identifi ed and correlated 
with non-syndromic sensorineural hearing loss (NSHL) (Alford 
2011). Variants of  GJB2 gene, accounting for up to 50% of NSHL 
inherited in autosomal recessive manner, clearly play a major 
role in the onset of this condition (Kenneson et  al, 2002).  GJB2 , 
expressed in the cochlea , encodes for the gap junction protein 
Connexin 26 (Cx26), whose function is crucial for intercellular 
communication, particularly in the recycling of potassium ions 
(K  ) which occurs through a lateral and a medial transcellular 
pathway. In the lateral route, K    effl uxing from outer hair cells 
is resorbed by Deiters ’ and tectal cells and fl ows via gap junc-
tions through Hensen ’ s, Claudius ’ and outer sulcus cells to effl ux 
into stroma. K  subsequently diffuses via gap junctions through 
type 1 fi brocytes and strial basal and intermediate cells into the 
intrastrial compartment. In the medial path, the K  released by 
the inner hair cells travels through inner phalangeal cells, border 
cells, inner sulcus cells directly or by way of limbal fi brocytes 
via gap junctions, similar to the spiral ligament, and is fi nally 
released back into the endolymph via the interdental cells (Spicer 
 & Schulte, 1998). 
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 Abstract 
 Objective: To evaluate the frequency of  GJB2 mutations and their correlation with phenotype in Sicilian non-syndromic sensorineural 
hearing loss (NSHL) patients.  Design: Sequencing of the coding region, basal promoter, exon 1, and donor splice site of the  GJB2 gene; 
screening for the presence of the two common  GJB6 deletions.  Study sample: A cohort of 102 Sicilian NSHL patients.  Results: Fifteen 
different mutations in  GJB2 and seventeen different genotypes were detected. No  GJB6 mutations were found. The hearing impairment 
was profound in the 64.72% of probands (mean PTA 0.25 – 4 kHz of 88.82    26.52 dB HL). A total of 81.37% of patients harboured at least 
one c.35delG allele; c.167delT and c.-23    1G  A were identifi ed in 10.78% and the 9.8% of patients respectively; c.35delG homozy-
gotes presented more severe hearing impairment (75.59% of profound hearing loss) and a higher mean PTA 0.25 – 4 kHz (96.79    21.11 dB 
HL) with respect to c.35delG/non-c.35delG and c.35delG/Wt patients (P    0.05).  Conclusions: This work underlines the role of c.35delG, 
c.167delT and c.-23    1G  A as the most frequent causes of NSHL in Sicily. The c.35delG frequency found is similar to those reported 
in other populations of the Mediterranean area. The analysis of genetic and audiologic data confi rmed a variability in the phenotype 
associated to a single genotype. 
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 A decreased synthesis or an altered function of Cx26 may there-
fore reduce the effi ciency of K  circulation leading to impaired 
hearing sensitivity (Wangemann, 2002). Additionally, as evidenced 
by the c.250G  C mutation (p.V84L) studied by Beltramello et  al 
(2005), Cx26 regulates also the permeability to Ca 2   -mobilizing 
messenger inositol triphosphate (IP3), allowing a metabolic cou-
pling between connected cells which is necessary to generate an 
endocochlear potential. 
 Also, mutations in  GJB6 , a gene encoding for Connexin 
30 (Cx30), a gap junction protein co-localized in the inner ear 
with Cx26, can be responsible for NSHL. Particularly, two 
large deletions in  GJB6 have been studied and have often been 
identifi ed in trans with single  GJB2 recessive mutations, sug-
gesting a possible recessive digenic inheritance (Del Castillo 
et  al, 2002, 2005).  GJB6 deletions are also linked with hearing 
impairment in patients who carry one  GJB2 recessive mutation 
 in trans, as a result of the abolition of an as-yet-unidentifi ed cis-
regulatory element responsible for the expression of the  GJB2 
gene in the inner ear. Common et  al (2005), analysing immuno-
histochemical data of the sweat glands of an individual compound 
heterozygous for c.35delG in  GJB2 and del( GJB6 -D13D1830) in 
 GJB6 , observed that Cx26 expression was affected by del( GJB6 -
D13S1830). The functional effect on Cx26 protein pointed to the 
disruption of a putative cis-regulatory element which appears 
to function with cell-type specifi city within the sweat gland. 
Rodriguez-Paris and Schrijver (2009), studying three unrelated 
individuals compound heterozygous for a  GJB2 mutation and 
del( GJB6 -D13S1830), demonstrated that the mutated  GJB2 allele 
in trans with del( GJB6 -D13S1830) was expressed, whereas the 
 GJB2 allele located in cis with the deletion was not expressed at 
all. Also del( GJB6 -D13S1854), similar to del( GJB6 -D13S1830), 
disrupts human  GJB2 expression at the transcriptional level, but, 
differently from del( GJB6 -D13S1830), it is associated with low 
residual  GJB2 expression (Rodriguez-Paris et  al, 2011). 
 The c.35delG mutation is by far the most common pathogenic  GJB2 
allele in Caucasians, (Denoyelle et  al, 1997) with a carrier frequency 
among European hearing individuals from 1% to 4% (Kenneson 
et  al, 2002). A South-North gradient in c.35delG carrier frequency 
was observed by Gasparini et  al (2000), with an average carrier fre-
quency of 2.8% in Southern Europe, higher than Central and North-
ern Europe (1.3%). Particularly the Mediterranean region presents the 
highest c.35delG frequency with Greece representing, as suggested 
by Lucotte (2007), the  ‘ geographical center ’ of this mutation; in 
Sicily, which was one of the regions of Ancient Greek colonization, 
Niceta et  al (2007), studying 1040 newborns who underwent  GJB2 
gene mutational screening, estimated a c.35delG carrier rate of 2.9%. 
 The main objective of this work was to study the frequency of 
 GJB2 mutations among Sicilian NSHL patients, trying to correlate 
the genotype with the severity of hearing impairment. In particular, 
considering the high prevalence of c.35delG found, we analysed the 
variability of the degree of deafness between c.35delG homozygotes 
and c.35delG heterozygotes. We compared also the genetic profi le 
of our sample with those of other populations of the Mediterranean 
area to evidence the main differences or similarities. 
 Materials and Methods 
 Study sample 
 We performed a retrospective study of audiological and genetic data 
that we collected from 102 patients with a variable degree of hearing 
impairment over recent years at the Audiology Department of the 
University of Palermo. All the included subjects, aged between 6 and 
65 years, were affected by bilateral NSHL and carried at least one 
 GJB2 mutation. Individuals with syndromic, unilateral or acquired 
hearing impairment were excluded from this study. A detailed history 
was taken to rule out the presence of environmental causes associated 
with SNHL (Joint Committee on Infant Hearing, 2007). After Ethi-
cal Committee approval, an informed consent was obtained from all 
participants and from parents of patients younger than 18 years old. 
 Clinical and audiometric evaluation 
 All patients underwent a physical examination of the ears through 
micro-otoscopy; audiometric tests and tympanograms were per-
formed in all subjects studied. Air conduction pure-tone aver-
age thresholds at frequencies 0.5 – 1 – 2 – 4 kHz (PTA 0.5 – 4 kHz ) were 
calculated for each ear and were used to classify hearing loss 
severity. Average thresholds ranging between 21 and 40 dB HL 
were defi ned as mild hearing loss, 41 – 70 dB HL as moderate, 
71 – 95 as severe hearing loss, and    95 dB HL as profound hear-
ing loss, as suggested by Liu et  al (2005). SNHL was classifi ed 
in  ‘ symmetrical ’ when in presence of inter-aural threshold differ-
ences    30 dB, and  ‘ asymmetrical ’ , when inter-aural threshold 
difference was    30 dB. 
 Mutation detection 
 After extracting DNA samples from peripheral blood, all subjects 
were analysed regarding the basal promoter, exon 1 and the coding 
region of  GJB2. 
 Genomic DNA was extracted classically from peripheral blood sam-
ples with the salting-out method. Molecular analysis of  GJB2 gene was 
performed with PCR and direct sequencing. Exon 1 was amplifi ed with 
the primers Cx1 forward (5 ′ -TCAAAGGAACTAGGAGATCGG-3 ′ ) 
and Cx1 reverse (5 ′ -CAAGGACGTGTGTTGGTCCAG-3 ′ ). Exon 2 
was amplifi ed with the primers GAP1 forward (5 ′ -CCTAT GACAAAC-
TAAGTTGGTTC-3 ′ ) and CONN reverse (5 ′ -GACAGCTGAGCAC 
GGGTTGCCTC-3 ′ ). 
 USB  ®  ExoSAP-IT  ®  PCR Product Cleanup protocol (37 ° C for 30 
minutes and then 95 ° C for 5 minutes) was performed to remove 
leftover primers and unincorporated dNTPs (Affymetrix, Inc.). 
 Cleaned up PCR products were sequenced from both ends, using 
the same primers as used for PCR reactions, with Applied Biosystem 
(ABI) PRISM  ®  BigDye  ®  Terminator v3.1 Cycle Sequencing Kits 
and analysed with ABI PRISM 3100 DNA automatic sequencer. 
 Following PCR protocol and using primers described by Del 
Castillo et  al (2005), the  GJB6 gene was also checked to rule out 
the presence of mutations del( GJB6 -D13S1830) and del( GJB6 -
D13S1854). 
 Statistical analysis 
 Statistical analysis was performed with Matlab  ®  computer pro-
gram;  χ 2 test, odds ratio (or) and/or exact test of Fisher were used, 
 Abbreviations 
 Cx Connexin 
 IQR Interquartile range 
 NSHL Non-syndromic sensorineural hearing loss 
 PTA Pure tone average 
 SNHL Sensorineural hearing loss 
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following usual conditions of application. Group data were expressed 
as percentages and median (95% confi dence intervals).Statistical 
comparisons between two groups were made using Student ’ s paired 
t-test. Signifi cance was set at 0.05. 
 Results 
 The study sample comprised 102 NSHL patients, 52 males (50.99%) 
and 50 females (49.01%) (Sex ratio    1.04). With a mean age of 
13.72    9.75 years (median 11.5 years), the majority of participants 
(75.49%) were within the range of 6 – 17 years. 
 Audiologic evaluation revealed that the 95.1% (97/102) of the 
total population was affected by symmetric SNHL, whereas the 
others (4.9%) presented an asymmetric hearing loss. The majority of 
subjects (96.08%, 98/102) had a stable SNHL and only four persons 
(3.92%) presented a progressive worsening of hearing. 
 As shown in Table 1, all degrees of hearing loss were observed 
in our population. The hearing impairment was profound in 66 
(64.72%), severe in 20 (19.6%), moderate in 13 (12.74%), mild in 
three (2.94%) patients. The mean PTA 0.25-4 kHz was 88.82    26.52 dB 
HL. Specifi cally, it was evidenced a progressive increase in mean 
hearing threshold values among 0.25 kHz (73.65    22.06 dB HL), 
0.5 kHz (83.45    23.67 dB HL), 1 kHz (93.38    24.38 dB HL), 
2 kHz (96.78    26.6 dB HL), and 4 kHz (96.83    27.79 dB HL) 
frequencies. 
 All subjects studied were positive to  GJB2 mutations; no variants in 
the basal promoter and exon 1 were identifi ed. No anomalies in  GJB6 
gene were found. Fifteen different mutations in  GJB2 were recognized, 
and seventeen different genotypes were detected in our study sample. 
 Of the 102 patients of our cohort, 83 (81.37%) harboured at least 
one c.35delG mutation, 11(10.78%) a c.167delT, and 10 (9.8%) 
a c.-23    1G  A; c.35delG, c.167delT, and c.-23    1G  A rep-
resented respectively the 76.3% (132/173), 6.93% (12/173) and 
5.78% (10/173) of all mutated  GJB2 alleles. Each remaining muta-
tion observed involved less than 4% of patients. 
 We classifi ed c.35delG carriers in three subgroups: the fi rst (G 1 ), 
composed by 49 patients who were homozygous for the c.35delG 
mutation; the second (G 2 ), and the third (G 3 ) respectively constituted 
by 15 subjects carrying a c.35delG mutation associated with other 
 GJB2 mutations in trans (c.35delG/ non-c.35delG), and 19 patients 
with a c.35delG/Wt genotype (Table 1). 
 The study of the audiologic profi le of G 1 group revealed a mean 
PTA 0.25-4 kHz of 96.79    21.11 dB HL (median    100 dB HL), with 
the 53.06% (26/49) of audiograms characterized by a  ‘ fl at loss ’ while 
the 46.94% (23/49) consisted in a  ‘ sky slope’ curve; thirty-nine 
subjects were affected by profound, eight by severe, and two by 
moderate SNHL (Figure 1). 
 Concerning G 2 patients, four different genotypes were recog-
nized (c.35delG/c.-23    1G  A, c.35delG/c.269T  C, c.35delG/
c.167delT, c.35delG /c.535 G to C) with a mean PTA 0.25-4 kHz of 
73.8    27.41 dB HL. A total of 53.33% of subjects (8/15) pre-
sented a fl at, 26.66% (4/15) an  ‘ U shaped ’ , and 20.01% (3/15) a 
sloping audiogram; ten patients had a severe to profound hearing 
impairment, whereas fi ve individuals were affected by mild to 
moderate SNHL. 
 From the analysis of the audiologic characteristics of G 3 group it 
resulted in a mean PTA 0.25-4 kHz of 87.78    26.9 dB HL; the majority 
of audiograms were represented by sloping curves (47.38%, 9/19), 
followed by fl at and  ‘ U shaped ’ audiograms in 36.84% (7/19) and 
15.78% (3/19) of cases respectively; eleven probands were affected 
by profound, four by severe, three by moderate and only one by 
mild SNHL. 
 With a prevalence of 79.59% (39/49), 40% (6/15), and 57.89% 
(11/19) of profound hearing loss among G 1 , G 2, and G 3 groups, the 
study of the audiologic phenotype revealed a statistical signifi cant 
difference between these groups (P    0.012). Distribution of hear-
ing thresholds (for 0.25 – 0.5 – 1 – 2 – 4 kHz) relative to G 1 , G 2, and G 3 
groups is reported in Figure 2. It is well shown that the highest 
mean PTA 0.25-4 kHz values were associated with c.35delG homozy-
gous genotype, with a statistical signifi cant difference with respect 
 Table 1. Frequency, hearing loss degree, and hearing threshold of all genotypes identifi ed in the cohort. 
 Hearing loss degree  Hearing threshold (dB HL) 
 Genotypes  N(%)  Mild  Moderate  Severe  Profound  Mean 
 Standard 
deviation  Median 
35delG/35delG (G 1 ) 49(48.03) 0 2 8 39 96.79    21.11 100
35delG/non-35delG (G 2 ) 15(14.7) 1 4 4 6 73.8    27.41 80
35delG/Wt (G 3 ) 19(18.62) 1 3 4 11 87.78    26.9 90
35delG / -23    1G  A 6(5.88) 0 1 4 1 65.33    24.06 70
35delG/167delT 5(4.9) 0 1 1 3 86.6    17.95 90
35delG/269T   C(L90P) 3(2.94) 1 1 0 1 43.66    19.86 45
167delT/Wt 3(2.94) 1 0 0 2 82.33    39.77 95
457G  A(V153I) /Wt 3(2.94) 0 1 1 1 80.33    23.71 80
167delT/139G  T(E47X) 2(1.96) 0 0 0 2 105.5    16.4 110
-23    1G  A/Wt 2(1.96) 0 1 1 0 53    19.6 47.5
101T   C(M34T)/Wt 2(1.96) 0 1 0 1 79    29.51 77.5
313del14/-23    1G  A 2(1.96) 0 0 1 1 87    21.49 80
167delT/167delT 1(0.98) 0 0 0 1 107 / /
35delG/535G   C(D179H) 1(0.98) 0 0 0 1 103 / /
310del14/551G   C(R184P) 1(0.98) 0 0 0 1 104 / /
101T   C(M34T)/269T   C(L90P) 1(0.98) 0 1 0 0 48 / /
380G  A(R127H)/Wt 1(0.98) 0 0 0 1 106 / /
301del3/Wt 1(0.98) 0 1 0 0 46 / /
Total * 102 3 13 20 66 88.82    26.52 90
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to G 2 group for all frequencies studied (P    0.01) and to G 3 limited 
to 1 – 2 – 4 kHz frequencies (P    0.05). 
 The study of a box plot (Figure 2) for each group revealed a 
lower variability in the degree of SNHL among G 1 patients (mean 
IQR 0.25-4 kHz    26 dB HL) than among G 2 (mean IQR 0.25-4 kHz    41.5 
dB HL) and G 3 subjects (mean IQR 0.25-4 kHz    40 dB HL). With 
a prevalence of 79.59% (39/49), 40% (6/15), and 57.89% (11/19) 
of hearing loss    90 dB HL for 2 – 4 kHz frequencies, it resulted a 
statistical signifi cant difference between G 1 , G 2, and G 3 (P    0.012); 
additionally, concerning 0.25 and 0.5 kHz frequencies, G 2 is associ-
ated with a higher variability in the distribution of data and a greater 
percentage (46.66%, 7/15) of patients affected by mild to moderate 
hearing loss than G 1 (P    0.032). 
 The c.167delT mutation was found in 11 probands (10.78%), 
associated with four different genotypes: c.167delT homozygous, 
c.167delT/c.35delG, c.167delT/c.139G  T, c.167delT/Wt. From 
the study of the audiologic data of all c.167delT carriers it resulted 
in a mean PTA 0.25-4 kHz of 90.18    26.49 dB HL and a profound 
SNHL in the majority of cases (72.72%, 8/11). Particularly, the fi ve 
subjects with a c.167delT/c.35delG genotype presented a variable 
degree of hearing loss (one moderate, one severe, and three pro-
found) and a mean PTA 0.25-4 kHz of 86.6    17.76 dB HL, lower than 
non c.35delG /c.35delG carriers but without any signifi cant differ-
ence (P    0.067). 
 The c.-23    1G  A mutation was identifi ed in 10 patients (9.8%) 
and distributed in three genotypes (c.-23    1G  A /c.35delG, 
c.-23    1G  A /c. 313del14, c.-23    1G  A /Wt; two probands 
were affected by profound, four by severe, three by moderate, and 
one by mild SNHL, with a mean PTA 0.25-4 kHz of 67.2    24.8 dB HL, 
lower than that of c.167delT carriers (P    0.006). 
 Discussion 
 Among more than 90 different  GJB2 mutations c.35delG accounts 
for up to 75% of mutated alleles in populations with European 
ancestry (Gasparini, 2000; Oguchi et  al, 2005). In the Mediterra-
nean area, with a great diffusion in the general population (carrier 
frequency of  ~ 1/30), c.35delG represents the most common patho-
logical  GJB2 allele associated with NSHL (Lucotte et  al, 2005). We 
evidenced in fact a c.35delG frequency of 76.3% among the total 
mutated  GJB2 alleles (132/173), in line with data relative to Tunisia 
(85.4%), Spain (82%) Algeria (76%), Turkey (76%), France (69%), 
Portugal (85%), Morocco (90.8%), and Greece (95.2%) (Rabionet 
et  al, 2000; Pampanos et  al, 2002; Kalay et  al, 2005; Marlin et  al, 
2005; Abidi et  al, 2008; Ammar-Khodja et  al, 2009; Chora et  al 
2010; Rihai et  al, 2013). 
 It is important to underline that  GJB6 mutations, which were not 
found in our cohort, represent only a small percentage of DFNB1 
mutations in our country; in fact, as demonstrated by many studies 
published previously,  GJB6 mutations were not or sporadically rec-
ognized in Italian NSHL patients, with an evident difference between 
Northern and Southern Italy (Del Castillo et  al, 2003; Gualandi et  al, 
















35delG/35delG 35delG /non-35delG 35delG/Wt
Profound Severe Moderate
 Figure 1. Relative frequencies of the degree of hearing loss in 
c.35delG/c.35delG, c.35delG/non-c.35delG, and c.35delG/Wt 















































































 Figure 2. Box plot. Distributions of PTA 0.25 – 4 kHz of patients 
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129 hearing-impaired infants from the Campania region, did not evi-
dence any  GJB6 mutations; Primignani et  al (2009) and Berto et  al 
(2009) instead found  GJB6 mutations only in three (0.4%) and fi ve 
patients (1.3%) of two cohorts from Northern Italy composed respec-
tively by 734 and 385 patients. On the contrary, in other countries 
of Western Europe such as Portugal and France, higher percentages 
of these mutations were observed (7.4% and 8.2% respectively) and 
also in Spain, where the  GJB6 mutations represent the second most 
frequent cause of prelingual deafness (Del Castillo et  al, 2003); Del 
Castillo et  al (2002) described previously this peculiar geographical 
distribution of  GJB6 mutations, especially of del( GJB6 -D13S1830), 
for which they suggested a  ‘ common founder ’ to justify the greater 
prevalence in certain populations. 
 In the 48.04% (49/102) of c.35delG homozygotes in our cohort, 
95.92% (47/49) had a severe to profound degree of hearing loss and a 
median PTA 0.5-2 kHz of 100 dB HL, similar to data reported by Hismi 
(90.9% of severe to profound HL and a median PTA 0.5-2 kHz of 104 
dB HL) and Cryns (91.56% of severe to profound HL and a median 
PTA 0.5-2 kHz of 102 dB HL) (Cryns et  al, 2004; Hismi et  al, 2006). 
Additionally, also from the comparison of our results with those 
of Iliadou (100% of severe to profound HL and a mean PTA 0.5-2 kHz 
of 99.78 dB HL) and Santos (100% of severe to profound HL and 
a mean PTA 0.5-2 kHz of 101.5 dB HL), no signifi cant difference was 
evidenced with respect to our data (Iliadou et  al, 2004; Santos et  al, 
2005). However, even if c.35delG/c.35delG was the most repre-
sented genotype among the studies cited, a certain variability in its 
prevalence emerged. Hismi et  al (2006) and Cryns et  al (2004), for 
example, found higher frequencies of this genotype (69.8% and 60% 
respectively), differently from our work (48.03%, 49/102) and from 
Iliadou et  al (2004) and Santos et  al (2005) (25.2% and 47.36% 
respectively). This discrepancy could be explained considering that 
the fi rst two authors cited included in their works only subjects 
carrying biallelic  GJB2 mutations. In fact, by excluding patients car-
rying only one  GJB2 mutation, the c.35delG/c.35delG percentage 
found in our cohort increases to 69.01% (49/71). Furthermore, it is 
clear that there is a correlation between this genotype and an audio-
logical phenotype characterized by severe to profound hearing loss, 
even if, cases of mild to moderate SNHL were previously reported 
(Wilcox et  al, 2000; Snoeckx et  al, 2005; Hismi et  al, 2006) and were 
also observed in our sample (2/49 of c.35delG/c.35delG carriers). 
The presence of different degree of hearing impairment in patients 
carrying the same  GJB2 mutations is not clearly understood, but 
many authors underlined the role of environmental factors or modi-
fi er genes as potential causes of this variability (Hismi et  al, 2006; 
Hilgert et  al, 2009; Picciotti et  al, 2009). 
 We compared the audiological phenotypes of patients homozy-
gous for c.35delG (G 1 ), c.35delG/non-c.35delG (G 2 ), and c.35delG/
Wt carriers (G 3 ). From this analysis a more severe hearing impair-
ment in G 1 subgroup (P    0.012) emerged, with a statistical signifi -
cant difference with respect to G 2 group for all frequencies studied 
(P    0.01) and to G 3 limited to 1 – 2 – 4 kHz frequencies (P    0.05); 
G 2 instead was characterized by a higher percentage (46.66%, 7/15) 
of patients affected by mild to moderate hearing loss with respect 
to G 1 patients (P    0.032). The study of distribution of PTA 0.25-4 kHz 
hearing thresholds showed in Figure 2 clearly reveals a close hearing 
loss spectrum for G 1 patients, with an accumulation of values around 
100 – 120 dB HL, especially for high frequencies. 
 Concerning c.167delT, the second most frequent mutation rec-
ognized in our cohort (10.78%, 11/102), it was observed associated 
with c.35delG in the 45.45% (5/11) of cases and was character-
ized by a moderate to profound hearing loss (mean PTA 0.25-4 kHz of 
90.18    26.49 dB HL); a statistically signifi cant difference emerged 
between the degree of hearing impairment of c.167delT/c.35delG 
and c.35delG/ c.-23    1G  A compound heterozygotes (P    0.03). 
The c.167delT/c.35delG genotype was carried by 4.9% (5/102) of 
our patients, with a median PTA 0.5-2 kHz    90 dB HL; our data are 
comparable to Cryns et  al (2005), Marlin et  al (2005), Snoeckx 
et  al (2005), and Hismi et  al (2006) who reported lower frequencies 
(   4%) of c.167delT/c.35delG carriers but with similar degree of 
hearing impairment (mainly severe to profound). 
 We found the c.-23    1G  A mutation in the 9.8% (10/102) of 
our cohort with a mild to profound spectrum of hearing loss; lower 
percentages were evidenced by Cryns et  al (2.89%), Snoeckx et  al 
(   1%), and Berto et  al (1.7%) studies (Cryns et  al 2005; Snoeckx 
et  al, 2005; Berto et  al, 2009). These studies identifi ed this mutation 
mainly in the heterozygous state and associated with c.35delG. From 
the comparison of the audiological profi le of our c.-23    1G  A 
/c.35delG patients (median PTA 0.5-4 kHz    70 dB HL) with literature 
data, the median hearing threshold seems to be superimposable; in 
fact Cryns et  al (2005) and Snoeckx et  al (2005) evidenced respec-
tively median values of 62 dB HL and 64 dB HL among 7 and 16 
patients with a c.35delG/ c.-23    1G  A genotype. On the contrary 
Santos et  al (2005) described two cases of profound SNHL associated 
with c.35delG/ c.-23    1G  A (mean PTA 0.5-2 kHz    97.9 dB HL); 
also in our cohort one patient was identifi ed with profound SNHL. 
All these data seems to be contradictory, refl ecting a variability in the 
phenotype associated to a single genotype and are not explainable 
on the basis of functional studies; in fact, D ’ andrea et  al (2002) and 
Shanin et  al (2002) demonstrated, for c.35delG and c.-23    1G  A, 
do not yield detectable Cx26 protein and mRNA respectively. This 
is inconsistent with the observation made by Snoeckx et  al (2005) 
and supported by our data, that c.35delG/ c.-23    1G  A compound 
heterozygotes had signifi cantly less severe hearing impairment com-
pared to c.35delG homozygotes (P    0.0001). 
 In conclusion, the present study, analysing the genetic profi le of 
NSHL Sicilian patients, highlights the role of certain  GJB2 muta-
tions (c.35delG, c.167delT, c.-23    1G  A) as the most frequent 
causes of congenital deafness in Sicily. Also from the study of 
our data, it emerged a real diffi culty to identify precise genotype-
phenotype correlations, even in cases of certain genotypes (as c.35delG 
homozygotes) which are mainly associated to a determinate degree 
of hearing impairment. Future research is necessary to provide 
additional data that could improve the knowledge about the effects 
of modifi er genes and environmental factors in the variability of 
audiologic phenotype. 
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